CRIS Cancer Foundation and the ICR are offering 2-3 year fellowships to support the development of outstanding early ...

The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...

More than 110,000 women were recruited from across the UK from 2004 to 2011. The study collects extensive, high-quality data through participant recruitment and follow up questionnaires; blood samples ...

Emma Godden, 51, has lost both her parents to cancer. Her dad, Arthur, passed away in 1986 when she was just 13 and her mum, Pauline, died in 2018. She reveals why she hopes to make a difference for ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

The Taught Course in Oncology is a day-release modular programme designed for medically qualified candidates who intend to pursue a professional career in some aspect of clinical or medical oncology, ...

The Adult Drug Development Unit (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, comprises an internationally-leading group of >100 staff focused on early ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

The Institute of Cancer Research is committed to the professional development of its staff. In addition to the training and support provided within individual teams, the Learning and Development Team ...

We discovered the function of the thymus and made key findings on the function of the two main subsets of lymphocytes, T cells and B cells. This was the fundamental basis for modern immunology.

The Adult Drug Development Unit (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, comprises an internationally-leading group of >100 staff focused on early ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...